Cboe Global Markets (CBOE)
Financials · financial exchanges
Cboe Global Markets is a premier provider of global market infrastructure, operating high-volume exchanges for options, futures, and equities, while leveraging proprietary volatility index products.
What Cboe Global Markets does
Cboe Global Markets is a leading provider of global market infrastructure and tradable products, operating stock, options, futures, and foreign exchange (FX) exchanges. The company offers a wide range of trading venues across North America, Europe, and Asia Pacific, along with proprietary index products, data services, and clearing solutions.
Themes: market infrastructure, volatility trading, derivatives trading, equities trading, FX trading, market data services, digital assets
Fundamentals
- Price$294.08 as of 2026-10-08 close
- Market cap$30.7B as of 2026-07-24 (share count; price 2026-10-08)
- 1-year return+21.9% 2025-10-08 close $241.26 → 2026-10-08 close $294.08
- P/E22.81 as of 2026-10-08
- ROE+21.4% FY2025, SEC XBRL
- Debt / equity0.26 as of 2026-09-03
- Revenue growth (YoY)+11.7% as of 2026-09-03
- Revenue CAGR (3y)+53.4% SEC XBRL
- Beta-0.24 as of 2026-09-03
- Last reported earnings2026-07-31 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +1.3%; at least 12 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How CBOE compares in its sector
- price-to-earnings ratiotop 25% 513 covered Financials peers, as of 2026-10-08
- return on equitytop 25% 559 covered Financials peers, as of 2026-09-03
- 3-year revenue CAGRtop 10% 347 covered Financials peers
- indicated dividend yieldbottom 25% 468 covered Financials peers, as of 2026-09-03
- free cash flow (absolute dollars, latest fiscal year)top 10% 430 covered Financials peers, as of FY2025
Position among covered Financials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
CBOE is not currently in any published Top 10 list. Its scores are below.
Top 10 score
64.1 #122 of 1,379 scored · #52 of 220 in Financials
Growth 79th (3-year revenue CAGR 53.4%, revenue growth year over year 11.7%) and profitability 77th (return on equity 21.4%); weakest is valuation (26th, price to earnings 22.8, price to book 5.5).
Scores as of 8 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, CBOE's dividend was covered by reported results (earnings payout 26%, free-cash-flow payout 17%). This describes past coverage, not a forecast.
- Earnings payout26% dividends / net income
- Free-cash-flow payout17% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Cboe Global Markets looks technically
Cboe Global Markets (CBOE) is trading 2.4% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed below its 200-day average about 1 trading day ago — a "death cross", a bearish long-term signal. A trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 20 (a reading of 25+ marks a strong trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 6 trading days ago (its momentum flipped positive). It just made a new 20-day high, its first since 2026-09-04, pushing above its recent trading range. It is 20.8% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 2.4% above its 200-day average, the long-term trend line — a longer-term uptrend | +2.4% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $286.74 | $286.74 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $287.09 | $287.09 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 10 calendar days ago — the swings before that are what the structure reading is measured on | 10 sessions |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 1 trading day ago — a "death cross", a bearish long-term signal | 1 session |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 2.4% above | +2.4% |
| Trend strength (14-day ADX) | a trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 20 (a reading of 25+ marks a strong trend) | 20.0 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30) | 60.5 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($252.82 to $298.00) — its "stochastic" reading is 91 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 91.3 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 6 trading days ago (its momentum flipped positive) | 6 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $371.18 | $371.18 |
|---|---|---|
| From the 52-week high | it is 20.8% below its 52-week high (its highest price of the past year) | -20.8% |
| Above the 52-week low | it is 29.5% above its 52-week low (its lowest price of the past year) | +29.5% |
| Below the 52-week high | it is 20.8% below its highest point of the past year | 20.8% |
| Since a 20-day breakout | it just made a new 20-day high, its first since 2026-09-04, pushing above its recent trading range | 1 session |
| Since a 55-day breakout | it made a new 55-day low about 9 trading days ago | 9 sessions |
| All-time high | its highest closing price on record is $371.18 (set on 2026-05-19) | $371.18 |
| Given back of the 52-week move | over the past year its closes ranged ($231.51 to $366.70), and it has recovered around half of its fall from last year’s high — 46% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $315.06 to $319.38. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 46.3% |
| From the all-time high | it is 20.8% below its all-time high | -20.8% |
| Nearest price level | it is trading 4.8% below a resistance level at $308.15 — a price it turned at four times since 2026-03-02, most recently on 2026-07-31. Since 2024-10-08 it has 13 such levels below the current price and 1 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +4.8% |
| All-time low | its lowest closing price on record is $19.60 (set on 2010-09-30) | $19.60 |
| Above the all-time low | it is 1400.4% above its all-time low | +1,400% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 73% of it) | 27th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $11.55 between its high and its low — about 3.9% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $11.55 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $254.21 and $290.67 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $254.21 – $272.44 – $290.67 |
| Typical daily range (% of price) | its price moves about 3.9% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.9% |
| Stretch from the 200-day average | it is trading 0.6 daily ranges above its 200-day average price (2.4% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 0.6 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.68× |
|---|
Analyst
2
| Change in the average price target | analysts have cut their average price target by 0.5% since the prior reading | -0.5% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating has improved toward "buy" since the prior reading | 0.28 toward buy |
Candlestick patterns
2
| Since a doji | 3 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 3 sessions ago |
|---|---|---|
| Since a bearish engulfing | 4 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 4 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-10-08 0.5% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.5% |
|---|---|---|
| Open gap | it gapped 10.4% above the previous close 7 sessions ago and has not traded back through the level it left behind at 253.26 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +10.4% |
| Gap filled | a 2.6% gap up opened on 2026-10-05 has been "filled" 3 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 3 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 4 sessions in a row, a +8.41% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 4 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 0.8 percentage points (the stock gained 0.3% while the market gained 1.0%) | -0.8% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 7.2 percentage points (the stock gained 11.0% while the market gained 3.8%) | +7.2% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 18.1 percentage points (the stock lost 0.7% while the market gained 17.5%) | -18.1% |
| vs market, 12 months | over the past 12 months this stock beat the market by 6.9 percentage points (the stock gained 21.9% while the market gained 15.0%) | +6.9% |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: trading above its 200-day average, a fresh 20-day high, MACD momentum is positive — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 3 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is thick, spanning 8.5% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 3% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $285.72 — a volume-weighted average of daily closes over 190 sessions, not a true tick-by-tick VWAP. | +2.9% |
|---|---|---|
| Vs the average paid since it last reported | the price is 3% above the average price paid since it last reported on 2026-07-31 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $285.60 — a volume-weighted average of daily closes over 49 sessions, not a true tick-by-tick VWAP. | +3.0% |
Double top, bearish — broke down · entry $280.75 · 48 sessions in
Price levels it has turned at before
CBOE last closed at $294.08 on 2026-10-08. Since 2024-10-08 it has turned at 13 prices below its last close and 1 above; the 3 nearest below and the nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $308.15 | Resistance | 4.8% above the last close | turned there four times · 2026-03-02 to 2026-07-31 |
| $279.19 | Support | 5.1% below the last close | turned there twice · 2026-01-26 to 2026-03-10 |
| $271.82 | Support | 7.6% below the last close | turned there three times · 2026-03-27 to 2026-08-19 |
| $260.47 | Support | 11.4% below the last close | turned there three times · 2025-11-12 to 2025-12-29 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Recent death cross (50-day crossed below 200-day) · Tested and reclaimed 200-day support · Pulled back from the 12-month high · Broke out to a new 20-day high · lagging the market | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingHold (2.78 mean, 1=Strong Buy…5=Strong Sell) — 15 analysts
- Mean price target$314.07 range $258.00 – $354.00; median $315.00
Analyst estimates, as of 2026-10-07. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for CBOE
- Consensus EPS estimate$3.43 next reporting period, as of 2026-10-07
- Estimate change, 30 days-$0.01552 (-0.5%) from $3.44, on 2026-09-02, 35-day window
- Readings revised upward0% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["dependence on trading volumes and market activity","intense competition and potential for margin compression in trading services","regulatory oversight and compliance risks across multiple global jurisdictions"]
What changed in the latest 10-Q
AI-assisted comparison of CBOE's 10-Q filed 2026-07-31 against the prior one filed 2026-05-01.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-07-31) adds a 'Recent Developments' section with a 'Strategic Realignment' subsection stating that on May 1, 2026, the Company announced additional actions related to its strategic realignment by optimizing resource allocation across the organization, expected to be substantially completed by the end of 2026.
- Newer filing (2026-07-31) adds a 'Cboe Predicts' subsection under 'Recent Developments' stating that on June 23, 2026, the Company announced the launch of the first products in its new prediction markets suite, Cboe Predicts, including binary option contracts based on the Mini-S&P 500 Index (XSP), listed under the symbols XSPBW and XSPBX.
- Newer filing (2026-07-31) adds 'Washington D.C.' to the list of office locations.
- Newer filing (2026-07-31) states that the Company expects the sale of Cboe Australia to close in the third quarter of 2026.
- Newer filing (2026-07-31) adds to the Options segment description that on June 23, 2026, the Company launched the first products in its new prediction markets suite, Cboe Predicts, a securities-based product listed on Cboe Options and centrally cleared by OCC.
- Newer filing (2026-07-31) removes 'Sarasota Springs' from the list of office locations (this is captured in removals).
- Removed:
- Older filing (2026-05-01) lists 'Sarasota Springs' among the Company's office locations; this location is not listed in the newer filing (2026-07-31).
- Reworded:
- Older filing (2026-05-01) describes the sale counterparty as 'TMX Group Limited'; newer filing (2026-07-31) describes it as 'TMX'.
- Older filing (2026-05-01) states 'which is reflective of how the Company's CODM reviews and operates the business'; newer filing (2026-07-31) states 'which are reflective of how the Company's CODM reviews and operates the business'.
- Older filing (2026-05-01) states 'including but not limited to employees, financial, and capital resources'; newer filing (2026-07-31) states 'including but not limited to employees, financial resources, and capital resources'.
- Older filing (2026-05-01) states 'Ms. Fischer is anticipated to assume oversight of Cboe's global cash equities and spot markets'; newer filing (2026-07-31) states 'Effective June 1, 2026, Ms. Fischer assumed oversight of Cboe's global cash equities and spot markets'.
- Older filing (2026-05-01) places the office locations sentence after the April 22, 2026 sale announcement paragraph; newer filing (2026-07-31) places it before the 2025 strategic review paragraph.
- Notes:
- The provided texts appear to be truncated mid-sentence in both filings (newer ends with 'fee structures than Cbo' and older ends with 'Europe and Asia Pacific. The Europe'), so only the portions included were compared; changes after these truncation points, if any, could not be assessed.
Risk Factors
- Added:
- Newer filing adds reference to Form 10-Q for the three months ended March 31, 2026 in the statement that no material updates were made to Risk Factors.
- Newer filing adds exhibit 10.1 (Amendment and Restatement Agreement dated June 23, 2026 relating to Cboe Clear Europe N.V. facility agreement).
- Newer filing adds exhibit 10.2 (Third Amended and Restated Credit Agreement dated as of July 24, 2026).
- Removed:
- Older filing removes the prior risk factor paragraph titled "If we fail to attract or retain highly skilled management and other employees our business may be harmed."
- Older filing removes from Item 5 the trading plan disclosure for Janet Froetscher (Director), including the table, the date of adoption, expiration date, and the sale of up to 4,884 shares of common stock.
- Older filing removes the associated footnote 1 stating the trading plan may expire earlier upon completion of transactions.
- Older filing removes the associated footnote 2 stating the trading plan was intended to satisfy the affirmative defense of Rule 10b5-1(c).
- Reworded:
- The share repurchase program initial authorization description changed from "an initial authorization for the Company to repurchase shares of its outstanding common stock of $100 million" (older) to "an initial authorization of $100 million for the Company to repurchase shares of its outstanding common stock" (newer).
- Share repurchase data updated: period changed from three months ended March 31, 2026 (161,227 shares at average $280.20, totaling $45.1 million, $569.4 million remaining) to three months ended June 30, 2026 (127,015 shares at average $256.61, totaling $32.6 million, $536.8 million remaining).
- Share repurchase monthly table periods changed from January/February/March 2026 figures to April/May/June 2026 figures.
- Employee stock purchase table description changed from "in the three months ended March 31, 2026 that were not part" to "in the three months ended June 30, 2026 that was not part".
- Employee stock purchase table periods changed from January/February/March 2026 figures (total 100,356 shares at $283.56) to April/May/June 2026 figures (total 4,797 shares at $317.09).
- Item 5 statement changed from disclosing specific director trading plans during the quarter to stating that no directors or executive officers adopted or terminated trading plans during the quarter.
- Exhibit list changes: older filing exhibit 10.1 and 10.2 are absent; newer filing includes those two exhibits, while both filings include exhibits 31.1, 31.2, 32.1, 32.2, 101.INS, 101.SCH, 101.CAL, 101.DEF, 101.LAB, 101.PRE, and 104.
- Notes:
- The provided newer text includes Risk Factors section plus subsequent Items 2-6 and signatures; the provided older text likewise includes those same Items. The comparison is limited to the supplied text.
- The Risk Factors section in newer filing states no material updates and refers to the prior Form 10-Q; older filing included a specific risk factor about workforce attrition. This risk factor is not present in the newer text.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 1 open-market sale by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 90 days · read to 2026-10-040 buys · 1 sell ($261376) — 1 selling insider
- Last 180 days · read to 2026-10-040 buys · 2 sells ($699320) — 1 selling insider
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-12. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about CBOE's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
U.S. House trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 6 matched disclosures for CBOE from U.S. House Clerk Periodic Transaction Report filings.
U.S. House trading disclosures →Institutional ownership (13F)
6 institutional 13F filers reported holding CBOE as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 22,772,045
- Reported value $5,526,092,357
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 3 increased, 3 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about CBOE's institutional holders → See what each manager we track holds →
Short interest (FINRA)
CBOE had 3,108,903 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
CBOE had 2.98% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 3.34 days to cover at the same settlement.
- Reported short interest (shares) 3,108,903
- Short interest (% of shares outstanding) 2.98%
- Prior settlement (shares) 3,062,548
- Reported change 1.51%
- Days to cover (reported) 3.34
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- CME Group (CME)
- Intercontinental Exchange (ICE)
- Nasdaq (NDAQ)
- London Stock Exchange Group
- Deutsche Börse AG (DB1)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CBOE vs…
Cboe Global Markets is found in…
Frequently asked questions
What does Cboe Global Markets (CBOE) do?
Cboe Global Markets is a leading provider of global market infrastructure and tradable products, operating stock, options, futures, and foreign exchange (FX) exchanges. The company offers a wide range of trading venues across North America, Europe, and Asia Pacific, along with proprietary index products, data services, and clearing solutions.
What sector is Cboe Global Markets (CBOE) in?
Cboe Global Markets (CBOE) is classified in the Financials sector. Its industry is financial exchanges.
Does CBOE pay a dividend?
Yes — Cboe Global Markets (CBOE) pays a dividend, with an indicated yield of about 1.26% and at least 12 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-09-03). Informational only — not financial advice.
Who are Cboe Global Markets's (CBOE) competitors?
Notable peers of Cboe Global Markets (CBOE) include CME Group, Intercontinental Exchange, Nasdaq, London Stock Exchange Group and Deutsche Börse AG. This peer set is informational only — not financial advice.
Has there been recent U.S. House stock trading in CBOE?
Yes — we hold 6 matched STOCK Act disclosures for CBOE from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Cboe Global Markets (CBOE) overbought or oversold right now?
Cboe Global Markets (CBOE) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 60, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CBOE come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.